Nature Research

SHERPA: Unknown

People

  1. Reuter
    Reuter
  2. Ladanyi
    Ladanyi
  3. Al-Ahmadie
    Al-Ahmadie
  4. Tickoo
    Tickoo
  5. Fine
    Fine
  6. Antonescu
    Antonescu
  7. Gopalan
    Gopalan
  8. Shia
    Shia
  9. Chen
    Chen
  10. Travis
    Travis

Groups

  1. Department of Pathology and Laboratory Medicine (1464)
  2. GSK Faculty (543)
  3. Surgery (393)
  4. GDMT, Pathology and Laboratory Medicine (356)
  5. Gynecology Disease Management Team (356)
  6. Department of Medicine (346)
  7. Tow Center for Developmental Oncology (TCDO) (327)
  8. Human Oncology and Pathogenesis Program (315)
  9. Solid Tumor Oncology Division (267)
  10. Sloan Kettering Institute Postdocs (233)
Search Within
Formats
  1. Meeting Abstract (1494)
  2. Journal Article (356)
  3. Editorial (19)
  4. Review (16)
  5. Correspondence (2)
  6. Guidelines (1)
Groups
  1. Department of Pathology and Laboratory Medicine (1464)
  2. GSK Faculty (543)
  3. Surgery (393)
  4. GDMT, Pathology and Laboratory Medicine (356)
  5. Gynecology Disease Management Team (356)
  6. Department of Medicine (346)

More Groups

People
  1. Victor Reuter (257)
  2. David Klimstra (218)
  3. Robert Soslow (197)
  4. Marc Ladanyi (191)
  5. Hikmat Al-Ahmadie (165)
  6. Satish Tickoo (161)

More People

Years
  1. 2025 (24)
  2. 2024 (28)
  3. 2023 (32)
  4. 2022 (119)
  5. 2021 (93)
  6. 2020 (64)

More Years

Publications
  1. Modern Pathology (1817)
  2. Nature Cancer (71)

Results (1888)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence of high-risk human papillomavirus (HPV) in HIV-positive males diagnosed with ASC-US in anal cytology specimens
    Meeting Abstract

    Yuan, J.; Friedlander, M. A.; Lin, O.; Savage, N. M.; Messias, N. C.; Ramalingam, P.; Reid-Nicholson, M. D.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Prognostic significance of the proposed IASLC/ATS/ERS revised classification of lung adenocarcinoma in 514 stage 1 lung adenocarcinomas (ADC)
    Meeting Abstract

    Yoshizawa, A.; Motoi, N.; Riely, G. J.; Kris, M.; Park, B. J.; Rusch, V. W.; Travis, W. D.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • The effect of tumor heterogeneity on the prognostic value of Ki67 labeling index in well-differentiated neuroendocrine tumors (NETs) metastatic to the liver
    Meeting Abstract

    Yang, Z.; Tang, L. H.; Klimstra, D. S.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Morphology and immunophenotype of ductal carcinoma in situ in triple negative breast cancer
    Meeting Abstract

    Wen, Y. H.; Akram, M.; Nehhozina, T.; Mohammed, H.; Norton, L.; Brogi, E.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Expression of id4, a BRCA1 downregulator, in triple negative breast cancer
    Meeting Abstract

    Wen, Y. H.; Akram, M.; Nehhozina, T.; Bowser, Z.; Norton, L.; Brogi, E.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Late recurring uterine smooth muscle tumors constitute a heterogeneous collection of leiomyosarcomas and STUMPs
    Meeting Abstract

    Veras, E.; Zivanovic, O.; Jacks, L.; Hensley, M.; Soslow, R.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Involvement of the VHL pathway in the pathogenesis of sporadic pancreatic endocrine neoplasms
    Meeting Abstract

    Veras, E.; Tang, L.; Klimstra, D.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Hypoxia-inducible gene 2 (HIG2) protein - Novel hypoxia marker for primary and metastatic renal cell carcinoma
    Meeting Abstract

    Tretiakova, M.; Hall, M.; Smertenko, T.; Hyjek, E.; Al-Ahmadie, H.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Grade progression of well differentiated neuroendocrine tumors (WDNETs) of the enteropancreatic system is distinct from poorly differentiated (PD) high grade neuroendocrine carcinomas (PDHGNECas)
    Meeting Abstract

    Tang, L. H.; Song, L.; Shia, J.; Vakiani, E.; Klimstra, D. S.
    Modern Pathology (2010)

    Fulltext@MSK | Save
  • Transformation of appendiceal goblet cell carcinoid tumor to adenocarcinoma is correlated with the status of KRAS mutation
    Meeting Abstract

    Tang, L. H.; Lau, C.; Schoepflin, A.; Shia, J.; Lassmann, S.; Ladanyi, M.; Werner, M.; Klimstra, D. S.
    Modern Pathology (2010)

    Fulltext@MSK | Save

    • Nature Research – authorized name for: